Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hill

Showing results (191-200 of 2,862) with videos related to

Pageof 287
Sort By:
Journal of Clinical Pharmacy and Therapeutics|April 26, 2003
Use of pharmacoeconomics in prescribing research. Part 2: cost-minimization analysis--when are two therapies equal?D Newby, S Hill
Communicable Disease and Public Health|October 16, 2004
Is 10iu/L anti-HBs protective after hepatitis B vaccination?S Hill, P Flanagan
Current Opinion in Rheumatology|June 18, 2004
Host-infectious agent interactions in the pathogenesis of rheumatic diseaseJ S Hill Gaston
Journal of Management in Medicine|December 9, 1993
Relationships between doctors and managers: the Scottish experienceA Bruce, S Hill
British Medical Journal|December 15, 1979
Multidisciplinary termsD Platt, S Hill
Journal of Clinical Pharmacy and Therapeutics|August 13, 2003
Use of pharmacoeconomics in prescribing research. Part 4: is cost-utility analysis a useful tool?R Brinsmead, S Hill
Journal of Clinical and Hospital Pharmacy|December 1, 1986
Therapeutic progress--review XXIII. Are we making progress in the treatment of acute stroke?S Hill, A Main
Journal of the Royal College of Physicians of London|January 23, 2019
The Aetiology of Rheumatoid ArthritisA G S Hill
Emergency Medicine Clinics of North America|April 18, 2000
The violent patientS Hill, J Petit
Acute Medicine|June 10, 2011
Cerebrospinal Fluid analysis in Suspected Subarachnoid HaemorrhageS Hill, A Pinto
Pageof 287

Showing results (191-200 of 2,862) with videos related to

Sort By:
Pageof 287
Journal of Clinical Pharmacy and Therapeutics|April 26, 2003
Use of pharmacoeconomics in prescribing research. Part 2: cost-minimization analysis--when are two therapies equal?D Newby, S Hill
Communicable Disease and Public Health|October 16, 2004
Is 10iu/L anti-HBs protective after hepatitis B vaccination?S Hill, P Flanagan
Current Opinion in Rheumatology|June 18, 2004
Host-infectious agent interactions in the pathogenesis of rheumatic diseaseJ S Hill Gaston
Journal of Management in Medicine|December 9, 1993
Relationships between doctors and managers: the Scottish experienceA Bruce, S Hill
British Medical Journal|December 15, 1979
Multidisciplinary termsD Platt, S Hill
Journal of Clinical Pharmacy and Therapeutics|August 13, 2003
Use of pharmacoeconomics in prescribing research. Part 4: is cost-utility analysis a useful tool?R Brinsmead, S Hill
Journal of Clinical and Hospital Pharmacy|December 1, 1986
Therapeutic progress--review XXIII. Are we making progress in the treatment of acute stroke?S Hill, A Main
Journal of the Royal College of Physicians of London|January 23, 2019
The Aetiology of Rheumatoid ArthritisA G S Hill
Emergency Medicine Clinics of North America|April 18, 2000
The violent patientS Hill, J Petit
Acute Medicine|June 10, 2011
Cerebrospinal Fluid analysis in Suspected Subarachnoid HaemorrhageS Hill, A Pinto
Pageof 287